Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-03-11 00:00:00 ET · period of report 2022-03-10 · accession 0001209191-22-018188 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-11 | 2022-03-10 | FATE | MENDLEIN JOHN | Dir | M - OptEx | $1.63 | +31.6K | 191.0K | +20% | +$51.4K |
| DM | 2022-03-11 | 2022-03-10 | FATE | MENDLEIN JOHN | Dir | S - Sale+OE | $35.02 | -31.6K | 171.5K | -16% | -$1.11M |
| D | 2022-03-11 | 2022-03-10 | FATE | MENDLEIN JOHN | Dir | M - OptEx | $0.00 | -31.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-10 | M | A | 31,562 | $1.63 | 191,017 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-10 | S | D | 12,069 | $35.48 | 159,455 | D | — | — | (F3) Represents the weighted average sale price of the shares sold from $35.13 to $35.75 per share. |
| 3 | Common | Common Stock | 2022-03-10 | S | D | 19,493 | $34.73 | 171,524 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $34.12 to $35.11 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 3. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-03-10 | M | D | 31,562 | $0.00 | 0 | D | $1.63 · — to 2022-03-12 | 31,562 Common Stock | (F4) This option is fully vested. |